RenovoRx (RNXT) EBITDA Margin (2025)
RenovoRx's EBITDA Margin history spans 1 years, with the latest figure at 1203.01% for Q3 2025.
- For Q3 2025, EBITDA Margin changed N/A year-over-year to 1203.01%; the TTM value through Sep 2025 reached 1312.99%, changed N/A, while the annual FY2024 figure was 20497.67%, N/A changed from the prior year.
- EBITDA Margin for Q3 2025 was 1203.01% at RenovoRx, down from 634.6% in the prior quarter.
- Across five years, EBITDA Margin topped out at 634.6% in Q2 2025 and bottomed at 1578.68% in Q1 2025.